Baldry Mark's Form 4 filing
X4 Pharmaceuticals, Inc (XFOR) · filed Feb 14, 2025
- Accession no.
- 0001628280-25-005698
- Filed
- Feb 14, 2025, 4:08 PM ET
- Trade date
- May 17, 2024-Feb 12, 2025
- Filing delay
- 273 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $19.3K. It was filed 273 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baldry MarkCIK 0001644137 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | Common Stock | PPurchaseAcquired | +21,646 | $0.677 | +$14,654.34 | 115,769 | Direct | |
| Nov 15, 2024 | Common Stock | PPurchaseAcquired | +13,404 | $0.343 | +$4,597.57 | 129,173 | Direct | |
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +600,000 | $0.00 | $0 | 729,173 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.